Pfizer announced Wednesday it has begun phases 2 and 3 of its pediatric clinical trial for Paxlovid, its COVID-19 antiviral treatment. The study will look into how effective and safe the treatment is ...

A new program from eMed and the NIH offers free tests and treatments, and you don't even need to leave your home.

An antiviral pill has shown to be effective in treating COVID-19, according to Phase 2 trial results released late last week. Should those promising results continue in large-scale Phase 3 trials, the ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear. Research studies ...

Pfizer announced on Wednesday that it has started clinical trials that could lead to the antiviral pill Paxlovid being available for children ages six and up to reduce the severity and duration of ...

Almost since the emergence of COVID-19, the U.S. has treated the disease as both a national and public health emergency. That ...

Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X WASHINGTON (AP) — U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans ...

Add Yahoo as a preferred source to see more of our stories on Google. Invivyd had also attempted to attain regulatory approval for pemivibart.Credit: Design_Cells via Shutterstock. (Design_Cells via ...

DURHAM, N.C. (WTVD) -- Remdesivir, an antiviral drug that was developed right here in Triangle, is playing a key role in President Trump's path to recovery from COVID-19. Right now, doctors at UNC and ...